Knee cartilage repair study halted early – too few patients to draw conclusions
NCT ID NCT04184687
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a procedure called nanofractures could help repair cartilage damage in the knee at the same time as ACL reconstruction. Only 4 people took part before the study was stopped early. Because of the very small number of participants, no meaningful conclusions can be drawn about whether nanofractures are helpful or not.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Nanofractures (a surgical procedure to stimulate cartilage repair)
- What this could lead to
- If successful, this approach could improve knee function and cartilage healing after ACL surgery.
- What could go wrong
- The study was terminated early with only 4 participants, so results are very limited and not reliable. It is unclear if nanofractures offer any benefit over standard ACL reconstruction alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARTILAGE INJURY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Ortopedico Rizzoli
Bologna, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your own stem cells could grow new knee cartilage
- New ACL surgery technique aims to boost healing with body's own tissues
- One surgery to fix two knee problems? pilot study tests combo approach
- New donor cartilage implant aims to fix knee damage in one surgery
- Cartilage repair registry halted: what we can learn from early data
- Oxygen chamber therapy put to the test for dozens of diseases